Prostate-specific membrane antigen (PSMA) is an integral membrane protein, mapped to chromosome 11q14, that is over-expressed by a high number of prostate carcinomas; this expression is further increased in higher grade carcinomas, in metastatic disease and in hormone refractory prostate carcinomas suggesting a role for this antigen in growth and progression and making it an interesting target for prostate carcinoma specific imaging and therapy. Here, FOLH1 is linked to metastatic neoplasm.